This protocol is judged by an institutional evaluation board, an impartial group that assessments any clinical trials involving humans. If a review entails a Routine I drug, after the board approves the protocol as ethical, the scientists must make an application for an investigational new drug (IND) amount with the FDA.This post features a listin